102 related articles for article (PubMed ID: 25801158)
1. Structure-activity relationships of benzhydrol derivatives based on 1'-acetoxychavicol acetate (ACA) and their inhibitory activities on multiple myeloma cell growth via inactivation of the NF-κB pathway.
Misawa T; Dodo K; Ishikawa M; Hashimoto Y; Sagawa M; Kizaki M; Aoyama H
Bioorg Med Chem; 2015 May; 23(9):2241-6. PubMed ID: 25801158
[TBL] [Abstract][Full Text] [Related]
2. TM-233, a novel analog of 1'-acetoxychavicol acetate, induces cell death in myeloma cells by inhibiting both JAK/STAT and proteasome activities.
Sagawa M; Tabayashi T; Kimura Y; Tomikawa T; Nemoto-Anan T; Watanabe R; Tokuhira M; Ri M; Hashimoto Y; Iida S; Kizaki M
Cancer Sci; 2015 Apr; 106(4):438-46. PubMed ID: 25613668
[TBL] [Abstract][Full Text] [Related]
3. 1'-acetoxychavicol acetate is a novel nuclear factor kappaB inhibitor with significant activity against multiple myeloma in vitro and in vivo.
Ito K; Nakazato T; Xian MJ; Yamada T; Hozumi N; Murakami A; Ohigashi H; Ikeda Y; Kizaki M
Cancer Res; 2005 May; 65(10):4417-24. PubMed ID: 15899834
[TBL] [Abstract][Full Text] [Related]
4. Structural development of benzhydrol-type 1'-acetoxychavicol acetate (ACA) analogs as human leukemia cell-growth inhibitors based on quantitative structure-activity relationship (QSAR) analysis.
Misawa T; Aoyama H; Furuyama T; Dodo K; Sagawa M; Miyachi H; Kizaki M; Hashimoto Y
Chem Pharm Bull (Tokyo); 2008 Oct; 56(10):1490-5. PubMed ID: 18827399
[TBL] [Abstract][Full Text] [Related]
5. Lipase-catalyzed preparation of optically active 1'-acetoxychavicol acetates and their structure-activity relationships in apoptotic activity against human leukemia HL-60 cells.
Azuma H; Miyasaka K; Yokotani T; Tachibana T; Kojima-Yuasa A; Matsui-Yuasa I; Ogino K
Bioorg Med Chem; 2006 Mar; 14(6):1811-8. PubMed ID: 16288877
[TBL] [Abstract][Full Text] [Related]
6. Biological activity of water-soluble inclusion complexes of 1'-acetoxychavicol acetate with cyclodextrins.
Azuma H; Aizawa Y; Higashitani N; Tsumori T; Kojima-Yuasa A; Matsui-Yuasa I; Nagasaki T
Bioorg Med Chem; 2011 Jun; 19(12):3855-63. PubMed ID: 21596572
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human alpha fetoprotein synergistically potentiates the anti-cancer effects of 1'-S-1'-acetoxychavicol acetate when used as a complex against human tumours harbouring AFP-receptors.
Arshad NM; In LL; Soh TL; Azmi MN; Ibrahim H; Awang K; Dudich E; Tatulov E; Nagoor NH
Oncotarget; 2015 Jun; 6(18):16151-67. PubMed ID: 26158863
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of nuclear factor κB by MIP-based drug combinations augments cell death of breast cancer cells.
Subramaniam M; Liew SK; In L; Awang K; Ahmed N; Nagoor NH
Drug Des Devel Ther; 2018; 12():1053-1063. PubMed ID: 29750018
[TBL] [Abstract][Full Text] [Related]
9. 1'-Acetoxychavicol acetate induces apoptosis of myeloma cells via induction of TRAIL.
Ito K; Nakazato T; Murakami A; Ohigashi H; Ikeda Y; Kizaki M
Biochem Biophys Res Commun; 2005 Dec; 338(4):1702-10. PubMed ID: 16289031
[TBL] [Abstract][Full Text] [Related]
10. 1'-Acetoxychavicol acetate inhibits RANKL-induced osteoclastic differentiation of RAW 264.7 monocytic cells by suppressing nuclear factor-kappaB activation.
Ichikawa H; Murakami A; Aggarwal BB
Mol Cancer Res; 2006 Apr; 4(4):275-81. PubMed ID: 16603641
[TBL] [Abstract][Full Text] [Related]
11. Anti-proliferative, apoptotic induction, and anti-migration effects of hemi-synthetic 1'
Liew SK; Azmi MN; In L; Awang K; Nagoor NH
Drug Des Devel Ther; 2017; 11():2763-2776. PubMed ID: 29075101
[TBL] [Abstract][Full Text] [Related]
12. Novel purification of 1'S-1'-Acetoxychavicol acetate from Alpinia galanga and its cytotoxic plus antiproliferative activity in colorectal adenocarcinoma cell line SW480.
Baradwaj RG; Rao MV; Senthil Kumar T
Biomed Pharmacother; 2017 Jul; 91():485-493. PubMed ID: 28477464
[TBL] [Abstract][Full Text] [Related]
13. Discovery of new benzhydrol biscarbonate esters as potent and selective apoptosis inducers of human melanomas bearing the activated ERK pathway: SAR studies on an ERK MAPK signaling modulator, ACA-28.
Satoh R; Hamada N; Yamada A; Kanda Y; Ishikawa F; Takasaki T; Tanabe G; Sugiura R
Bioorg Chem; 2020 Oct; 103():104137. PubMed ID: 32763519
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and biological evaluation of benzofuran- and 2,3-dihydrobenzofuran-2-carboxylic acid N-(substituted)phenylamide derivatives as anticancer agents and inhibitors of NF-κB.
Choi M; Jo H; Park HJ; Sateesh Kumar A; Lee J; Yun J; Kim Y; Han SB; Jung JK; Cho J; Lee K; Kwak JH; Lee H
Bioorg Med Chem Lett; 2015 Jun; 25(12):2545-9. PubMed ID: 25953156
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of pregnenolone/2-cyanoacryloyl conjugates with dual NF-κB inhibitory and anti-proliferative activities.
Song JL; Zhang J; Liu CL; Liu C; Zhu KK; Yang FF; Liu XG; Figueiró Longo JP; Alexandre Muehlmann L; Azevedo RB; Zhang YY; Guo YW; Jiang CS; Zhang H
Bioorg Med Chem Lett; 2017 Oct; 27(20):4682-4686. PubMed ID: 28919340
[TBL] [Abstract][Full Text] [Related]
16. Small molecule 1'-acetoxychavicol acetate suppresses breast tumor metastasis by regulating the SHP-1/STAT3/MMPs signaling pathway.
Wang J; Zhang L; Chen G; Zhang J; Li Z; Lu W; Liu M; Pang X
Breast Cancer Res Treat; 2014 Nov; 148(2):279-89. PubMed ID: 25301089
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of 3,4-dihydro-2H-benzo[h]chromene derivatives as potential NF-κB inhibitors.
Choi M; Hwang YS; Kumar AS; Jo H; Jeong Y; Oh Y; Lee J; Yun J; Kim Y; Han SB; Jung JK; Cho J; Lee H
Bioorg Med Chem Lett; 2014 Jun; 24(11):2404-7. PubMed ID: 24792464
[TBL] [Abstract][Full Text] [Related]
18. Anti-proliferative effect of chalcone derivatives through inactivation of NF-κB in human cancer cells.
Venkateswararao E; Sharma VK; Yun J; Kim Y; Jung SH
Bioorg Med Chem; 2014 Jul; 22(13):3386-92. PubMed ID: 24835787
[TBL] [Abstract][Full Text] [Related]
19. Effects of ATRA combined with citrus and ginger-derived compounds in human SCC xenografts.
Kleiner-Hancock HE; Shi R; Remeika A; Robbins D; Prince M; Gill JN; Syed Z; Adegboyega P; Mathis JM; Clifford JL
BMC Cancer; 2010 Jul; 10():394. PubMed ID: 20659317
[TBL] [Abstract][Full Text] [Related]
20. Triptolide overcomes dexamethasone resistance and enhanced PS-341-induced apoptosis via PI3k/Akt/NF-kappaB pathways in human multiple myeloma cells.
Yang M; Huang J; Pan HZ; Jin J
Int J Mol Med; 2008 Oct; 22(4):489-96. PubMed ID: 18813856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
